Ignite Creation Date:
2025-12-25 @ 12:21 AM
Ignite Modification Date:
2026-01-07 @ 7:51 PM
Study NCT ID:
NCT00082758
Status:
COMPLETED
Last Update Posted:
2015-02-12
First Post:
2004-05-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma
Sponsor:
Children's Oncology Group
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
ANBL0322
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |